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Abstract: The design and fabrication of custom-tailored microarrays for use 
as phantoms in the characterization of hyperspectral imaging systems is 
described. Corresponding analysis methods for biologically relevant 
samples are also discussed. An image-based phantom design was used to 
program a microarrayer robot to print prescribed mixtures of dyes onto 
microscope slides. The resulting arrays were imaged by a hyperspectral 
imaging microscope. The shape of the spots results in significant scattering 
signals, which can be used to test image analysis algorithms. Separation of 
the scattering signals allowed elucidation of individual dye spectra. In 
addition, spectral fitting of the absorbance spectra of complex dye mixtures 
was performed in order to determine local dye concentrations. Such 
microarray phantoms provide a robust testing platform for comparisons of 
hyperspectral imaging acquisition and analysis methods. 
© 2012 Optical Society of America 
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measurement, and metrology; (170.0170) Medical optics and biotechnology; (170.3880) 
Medical and biological imaging; (170.0180) Microscopy; (350.4800) Optical standards and 
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1. Introduction 
The design and characterization of analysis methods for hyperspectral imaging (HSI) is often 
complicated by the need for appropriate test samples. Even if target signatures are known, the 
preparation of separate “pure” spectral signals may not be feasible. Indeed, for most scenarios, 
the detected hyperspectral signals will rarely originate from a single source. For example, a 
chemical absorption signature will be convolved with light scattering, noise, and instrumental 
response functions. Therefore, the preparation of phantoms containing known complex 
chemical compositions with set spatial profiles would allow for the robust characterization of 
appropriate experimental parameters and statistical analysis methods. 
Printed microarrays offer the potential for high-throughput analysis, and are often 
employed in nucleotide and protein assays. Generally, a microarray reader records one to four 
fluorescence channels, with spectral bandwidth determined by optical filters, and compares 
the signal to the background fluorescence. Replacing the filter-based detectors with a 
hyperspectral imaging system has been shown to identify and eliminate sources of error, such 
as spatially localized contaminants [1]. Background fluorescence can be removed by post-
processing, or reduced via structured illumination of the sample [2]. Additionally, the narrow 
bandwidths and numerous channels of hyperspectral imagers allow resolution of fluorophores 
with similar emission maxima when compared to optical filters [3]. For example, Erfurth et al. 
[4] calculated a cross-talk of typically <1% between a series of fluorophores after 
hyperspectral processing. Our ultimate goal is to use hyperspectral imaging techniques for cell 
and tissue imaging [5]. Here, we demonstrate that microarrays can be expanded beyond 
fluorescence microscopy of in vitro samples to serve as tools for characterizing hyperspectral 
absorbance or reflectance measurements for complex, spatially distributed biological systems. 
A key challenge in optical spectroscopy and microscopy of tissues lies in decoupling their 
absorption and scattering signals [6]. Depending on the particular system, the isolation of one 
such signal may be sufficient, or both signals may need to be considered together to determine 
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microscopy, have been used to study organelles within single cells during apoptosis without 
the need for exogenous stains [7]. Additional medical studies include the detection of skin 
cancers in mice [8] and the visualization of tumor hypoxia [9]. Non-invasive imaging 
facilitates the monitoring of clinical treatments. For example, skin tissue oxygenation levels 
have been monitored during nitric oxide inhalation by patients [10] and induced vasodilation 
in the feet of diabetics [11] were followed using reflectance hyperspectral imaging. Coupling 
hyperspectral instruments to fundus cameras allowed for ophthalmological information to be 
obtained − notably retinal hemoglobin oxygen saturation levels [12,13]. 
Indeed, reflectance or absorbance hyperspectral imaging is well suited to the measurement 
of hemoglobin oxygenation saturation. Yet, several complicating factors may come into play 
when investigating the analysis of blood oxygenation. Due to the difficulties in preparing 
appropriate standards, such HSI systems are typically calibrated only at fully saturated and 
desaturated levels [9]. While hemoglobin and  deoxygenated hemoglobin account for the 
majority of the spectral signal, their spectral signatures extensively overlap. Additionally, 
other chromophores in the sample may confound the analysis. Any statistical analysis of the 
data set from such a sample must either determine the spectral signatures and amounts of such 
interference, or have been sufficiently tested in order to determine the significance of any 
error introduced by ignoring these factors. 
There are several advantages to using a fully controllable system, where various 
interfering signals can be introduced. However, phantoms designed to mimic biological 
materials must be carefully considered, as a tradeoff may exist between their manageability 
and their biological relevance. Typically, it is not feasible to isolate a lone spectral signature, 
and any model must therefore allow for the presence of overlapping signals. Here, we 
examine the preparation of microarray phantoms that allows for spatial control of sample 
placement and a wide range of spectral profiles. These arrays have been analyzed using a 
hyperspectral imaging system capable of measuring biological samples [5]. We demonstrate 
the ability to prepare array phantoms containing complex hyperspectral signatures, and detail 
the initial analysis of these arrays as statistical benchmarks. Specifically, we present the 
printing of spot arrays consisting of single chromophore dyes, or mixtures of dyes, and show 
how they may be measured by hyperspectral absorption imaging. Our model system allows 
for exceptional flexibility in the preparation of a large number of samples. By imaging diverse 
arrays of known chromophore concentrations (or other appropriate samples), the robustness of 
the analysis techniques can be determined. Additionally, the number of interfering signals can 
be easily adjusted. This technique can be readily generalized to the printing of other 
chromophores or fluorophores, including biological materials such as proteins containing 
distinct spectral signatures. 
2. Experimental methods 
Water soluble dyes were selected for the printing based on their absorption profiles, spanning 
the visible range. Dyes were purchased from Sigma-Aldrich. In particular, the following four 
dyes were used: acid red 1 (AR), new coccine (NC), erioglaucine (EG), and brilliant blue R 
(BBR). Two sample types were employed. In the first, three dyes (AR, EG, BBR) having 
significantly different absorption spectra were mixed in various amounts and printed. In the 
second, two dyes with similar absorption spectra (AR and NC) were mixed and printed. Dyes 
were dissolved in water to create stock solutions that provided absorption spectra of similar 
magnitude (w/w: 4.9% AR; 7.0% NC; 5.1% BBR; 1.9% EG). Stock solutions were then 
mixed and combined with 75% polyethylene glycol (PEG, 600 amu) to create a dye solution 
in water containing 50% PEG. The PEG solution ensures high quality print uniformity, 
allowing for spots of similar size and preventing dye crystallization [14]. These solutions then 
were loaded into a microtiter plate and printed onto SuperAmine2 glass slides (ArrayIt, 
Sunnyvale,  CA),  with  a  spot  spacing  of  250  μm.  For  ease  of  comparison,  the  highest 
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concentration. 
Dye arrays were printed with a SpotBot II personal microarrayer robot (ArrayIt), using 
custom methodology to generate the XML code needed to drive the instrument (i.e., a 
SPOCLE file for the SpotBot II). First, the array was designed, using Photoshop to create an 
8-bit RGB TIFF file. This image file is considered the map for the desired phantom, with each 
RGB color code representing a given sample (i.e., 3 “digits” of 0-255). A typical array image 
encompasses 20 x 20 virtual “pixels,” where each “pixel” corresponds to single-color square 
in the array of multiple squares in a Photoshop image area, and may contain multiple sub-
arrays within this area. Specifically, the two array phantoms examined in this paper consist of 
six replicate subarrays (with 6 x 9 pixels dimensions). Second, a text file was created that acts 
as a “key” for the map. This text file indicates the microtiter plate well corresponding to a 
given color in the image. For example, the color red (255, 0, 0) may correspond to well A1. 
Additionally, a blank color (e.g., white) may be used to indicate that no printing should occur 
at a given location. Third, a MATLAB (Mathworks, Natick, MA) script was used to create the 
final XML file by linking the image file and the text file key. Additional inputs into the 
MATLAB script can be used to alter the spot spacing, the number and frequency of washing 
steps, whether to preprint spots in a separate location, and whether to repeat the arrays on a 
single slide or on multiple slides. The general work flow is illustrated in Fig. 1, where the 
printing was performed on glossy photo paper just to facilitate viewing, where the actual 
samples for analysis were prepared by printing spots on glass slides. An example of the 
MATLAB code is provided as supplementary material. 
 
Fig. 1. (a) A printing design is chosen or created in a program such as Photoshop. Here the U.S. 
Department of Commerce logo, containing 5 colors, is shown in a reduced image size and 
consists of five colors. (b) The colors represent printing wells (four of which correspond to four 
distinct colors, with white indicating that a spot should not be printed at that location). (c) The 
image and well codes are fed into MATLAB, which generates the appropriate code to drive the 
SpotBot II (see Media 1), as shown here. (d) The image was printed on Epson glossy photo 
paper to illustrate the printing procedure by showing the spots macroscopically. (e) A close-up 
comparison of a region of the inputted image and its corresponding printed image. 
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whose detailed description, including the spectral bandwidth and results of background 
correction methods, is published elsewhere [5,14]. In this experiment, an OL490 tunable 
spectral light engine (Gooch and Housego, Orlando, FL) was coupled to a Zeiss Axiovert 100 
inverted microscope, resulting in a spectral bandwidth of approximately 10 nm. Images were 
collected by sweeping the source in 5 nm increments from 400 nm to 700 nm. The transmitted 
light image was detected by a Hamamatsu Orca-R2 CCD camera (Hamamatsu, Japan). A 
focusing motor was used to correct for chromatic aberration of the objective lens at each 
wavelength. The OL490 selects each spectral bandwidth by turning only micromirrors 
corresponding to each bandwidth in the on position. Even when all mirrors of the OL490 are 
in the off position, some stray light exists and will be detected by the CCD. Here we define 
the dark signal of the system to include the electronic CCD noise and the signal from this 
stray light. Due to the change in the focus of the system, the dark signal of the hyperspectral 
microscope was found to be spectrally-dependent (i.e., the contribution of this stray light to 
the dark signal depends on the objective z-position). Therefore,  a dark signal image was 
collected after each frame of the signal image. In addition to imaging the phantom sample, a 
reference image was collected from a region of the glass slide lacking spots. This area served 
as a reference to characterize the intensity and spatial homogeneity of the illumination light at 
each wavelength. 
Post-processing of the signal and background data cubes was performed to transform the 
data set into absorbance values. A pixel-by-pixel correction method similar to that used by 
Geladi et al. [15] was performed to remove dark signal and nonhomogeneous illumination 
artifacts. In our analysis, the sample intensity detected at pixel x,y for a given wavelength, λ, 
is written as Ix,y,λ. A portion of this intensity is due to the dark signal inherent from the 
illumination source and camera, which we write as Idark,x,y,λ. Similar intensities are determined 
for the background (i.e., the intensity detected if no sample is present), which are designated 
Io,x,y,λ and Io,dark,x,y,λ. Therefore, the absorbance at pixel x,y,λ can be calculated by 
 
,, ,,,
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,,, , ,,,
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−
   (1) 
 
Fig. 2. Examples of detected images from the hyperspectral data cubes of a printed spot on 
glass. Signal and dark signal intensities are shown for the glass background datacube (Io), and 
the sample datacube (I). These intensities are used to calculate the absorbance image A. All 
images are from the same spatial location on the CCD (i.e., the same x,y coordinates). Ring 
patterns within the hemispherical PEG-based spot are caused by scattering and refraction of the 
illumination light. 
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are presented in Fig. 2. 
3. Results and discussion 
A microarray pattern consisting of spots containing individual or mixtures of three dyes (AR, 
BBR, and EG) was designed and analyzed (Fig. 3). The array contains 5%–100% of each 
individual dye as well as mixtures of two or three dyes. Additional spots of PEG without any 
dye are also included and serve as reference signals. An absorbance image of the printed 
microarray at 695 nm is shown in Fig. 3(b). The spots are hemispherical, consisting of PEG 
and dissolved dyes. In general the spots were uniformly printed; however some changes in the 
spot size occurred, likely caused by a minor obstruction in the tip of the SpotBot during 
printing. The imaged spots exhibit wavelength-dependent absorption and scattering signals. 
For example, the close-up view of a PEG spot can be observed in Fig. 2. The detected 
absorbance at a pixel depends strongly on the scattering and refraction of light by the 
hemispherical spot. Such factors complicate quantitative hyperspectral analysis, but are 
representative of some of the challenges that exist in biomedical samples. Because the 
demonstration of the preparation of these hyperspectral imaging phantoms is the primary 
focus of this paper, analysis of the microarrays here was performed by averaging the signals 
from individual spots. First, the spots were identified by thresholding the image at the 695 nm 
frame. The mean absorbances for all pixels within a spot were determined for each 
wavelength. Additionally, the mean background intensity was determined from all pixels 
outside the spots. Sample signals were corrected using this mean background signal. 
The mean scattering signals from within a printed spot can be observed by monitoring the 
recorded absorbance from the reference spots containing only PEG (Fig. 3(c), top). An 
individual dye spectrum is the combination of the dye absorbance profile and the scattering 
signal. Small spectral differences for the PEG (scattering) spots were observed across the field 
of view as a result of changes in the scattering due to spot shape or position. As detailed 
analysis of the scattering signal is outside the scope of this paper, approximate methods were 
performed to simply remove the scattering components. For example, to recover a reference 
“pure” dye signal, the spectra of the 100% dyes were obtained by subtraction of the most 
similar PEG signals. 
 
Fig. 3. (a) A pattern designed in Photoshop (shown with identifying notations), was used to 
generate a test microarray that consists of PEG spots containing varying amounts of three 
spectrally dissimilar dyes (AR, BBR, EG). (b) This sample was imaged by a hyperspectral 
microscope (shown here for 695 nm illumination). Scalebar is 200 μm . (c) The absorptio n 
spectra of dye spots measured by the hyperspectral microscope are shown before (top) and after 
(bottom) subtraction of the PEG background. 
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Single dye concentrations were varied from 1% to 100%, and a large array of mixtures were 
printed (not shown). Examples of the 100% relative concentration spectra, prior to subtraction 
of the PEG signal, are shown in Fig. 4. This pair of dyes provides a test platform for analysis 
methods that may seek to differentiate two biological chromophores having extensive overlap 
(e.g., oxygenated and deoxygenated hemoglobin). 
More intensive hyperspectral imaging analysis of such phantoms has been presented 
elsewhere, comparing the Least Absolute Shrinkage and Selection Operator (LASSO) and 
spatial LASSO [16]. However, a simplified analysis was performed in the current study by 
least-squared fitting of a linear combination of the dye spectra. The spectra obtained from the 
100% dye spots were used to fit the remaining microarray spots (including the PEG spots), 
using a linear combination of the dye signals, and including a constraint of non-negativity. 
Again, the best-matched PEG signal was used in this fitting to match the scattering signal. For 
example, for the two dye phantom the fitting function was 
  , 100, 100, , , fit AR AR NC NC PEG A c A c A A offset λ λ λλ = + ++    (2) 
where Afit,λ is the fitted absorbance at wavelength λ, cAR and cNC are the relative concentrations 
of dyes AR and NC, AAR100,λ and ANC100,λ are the PEG subtracted absorbances of the dyes at 
100% relative concentration, and APEG,λ is the absorbance of the best fit PEG spectrum. APEG,λ 
is calculated directly from Eq. (1), while AAR100,λ and ANC100,λ are calculated by correcting the 
signal calculated in Eq. (1) by the appropriate PEG signal (resulting in PEG corrected spectra 
similar to the lower spectra in Fig. 3(c)).  Figure 5(a)  displays selected, experimentally 
measured and fitted dye spectra from the microarray appearing in Fig. 3. Figure 5(b) shows 
example fittings from the two spectrally similar dyes. The experimental and fitted spectra 
match very well in these cases. Deviation is noticeable near the extreme wavelengths (i.e., 400 
nm and 700 nm) where the illumination intensity is weaker, which results in larger errors in 
the absorbance calculation. The linear mixing method worked reasonably when only one dye  
 
Fig. 4. The absorbance spectra of two pure but spectrally similar dyes (AR and NC) and the 
mean PEG signal, obtained from a microarray phantom. 
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Fig. 5. (a) Spectral data collected from the microarray shown in Fig. 3 are displayed along with 
fitted spectra, obtained by a linear combination method. (b) The same process, applied to two 
dyes with similar absorption profiles. The number after the name of a dye indicates the 
percentage of the dye relative to the maximum printed solution concentration. 
was present within a spot, even when significant spectral overlap existed between the two 
candidate dyes (see Table 1). In these cases, the measured and fitted results were very 
consistent across replicate microarrays printed on the same slide. Similar results were 
observed for the phantom with the three dyes. However, spots that contained dye mixtures 
were more challenging, and the results were often erroneous. For example, the fitting often 
found more NC present than the real value when this dye was mixed with AR (see Table 1). 
While, the linear mixing method often was superior for the single AR or NC dyes, analysis of 
the complex dye mixtures was better performed by the spatial LASSO, which typically 
resulted in dye concentrations that more closely matched the actual value. 
Table 1. Expected and calculated concentrations from linear mixing analysis of two dyes: 
AR and NC. Concentrations are relative to the maximum printed solution concentration. 
Standard deviation is calculated from the analysis of three different microarrays on the 
same slide. 
Sample 
Expected 
[AR]  Calculated [AR] 
Expected 
[NC]  Calculated [NC] 
AR050  50  0.46 ± 0.014  0  0.00 ± 0.007 
AR020  20  0.20 ± 0.017  0  0.01 ± 0.016 
AR010  10  0.10 ± 0.002  0  0.00 ± 0.000 
AR005  5  0.06 ± 0.015  0  0.00 ± 0.000 
AR001  1  0.01 ± 0.017  0  0.00 ± 0.000 
NC050  0  0.03 ± 0.027  50  0.52 ± 0.025 
NC020  0  0.03 ± 0.036  20  0.19 ± 0.048 
NC010  0  0.03 ± 0.022  10  0.08 ± 0.040 
NC005  0  0.04 ± 0.002  5  0.00 ± 0.000 
NC001  0  0.00 ± 0.000  1  0.00 ± 0.000 
AR050:NC100  50  0.16 ± 0.098  100  1.40 ± 0.170 
AR050:NC050  50  0.25 ± 0.220  50  0.46 ± 0.266 
AR010:NC020  10  0.06 ± 0.055  20  0.23 ± 0.148 
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Spectral analysis of biological systems generally is quite difficult, and care must be taken to 
properly test the measurement process. The advantage of using a microarray phantom is that it 
can be tailored to a given biological target. For example, remote sensing analysis of 
phytoplankton pigments is complicated due to the relationships between pigment 
concentrations [17]. In performing in vivo melanoma diagnostics, the spectral differentiation 
between malignant melanoma and dysplastic nevi is crucial [18]. For both of these biological 
phenomena, initial testing of the statistical methods for image analysis could be performed by 
the preparation, printing, and analysis of microarray phantoms containing interacting dyes or 
pigments. The modeling of scattering systems is particularly relevant to the hyperspectral 
imaging of agricultural products, which require the decoupling of significant scattering and 
contour contributions to the measured spectra [19]. Similar issues also arise when analyzing 
interacting cell populations, such as those comprising complex biofilms [20]. A microarray 
platform with spots of varying size could be used as a test platform to deduce the influence of 
spot curvature on the analysis results. 
Small scale systems, such as those illustrated here to print custom-designed microarray 
phantoms are attractive tools. In particular, they provide the ability to manufacture a large 
number of standards, which can be readily shared across institutions and used to compare 
different hyperspectral imagers and analysis methods. Additionally, the preparation of a 
microarray allows quick exploration of the relevance and relative quantities of various 
components considered for tissue phantoms. The spatial sizes can be scaled up for larger area 
standards once the desired composition is determined from the microarray analysis. 
Appendix A: Supplementary material 
Example MATLAB code to program the SpotBot II is provided as supplementary material 
(Media 1). 
Appendix B: Disclaimer 
Certain commercial equipment, instruments, or materials are identified in this manuscript are 
to foster understanding. Such identification does not imply recommendation or endorsement 
by the National Institute of Standards and Technology, nor does it imply that the materials or 
equipment identified are necessarily the best available for the purpose. 
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